Accuray Incorporated (ARAY)
Automate Your Wheel Strategy on ARAY
With Tiblio's Option Bot, you can configure your own wheel strategy including ARAY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ARAY
- Rev/Share 4.5247
- Book/Share 0.4822
- PB 2.7167
- Debt/Equity 4.3234
- CurrentRatio 1.6392
- ROIC 0.0081
- MktCap 134947030.0
- FreeCF/Share 0.1851
- PFCF 7.0902
- PE 200.1497
- Debt/Assets 0.4426
- DivYield 0
- ROE 0.0143
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Positive
ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.
Read More
Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities
Published: June 06, 2025 by: PRNewsWire
Sentiment: Neutral
MADISON, Wis. , June 6, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that, after an extensive review over the last several months, including the evaluation of numerous potential financing partners, it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2026 (the "Notes") to exchange an aggregate of $82.0 million principal amount of Notes for an aggregate of 8,881,579 shares of the Accuray's common stock (the "Shares").
Read More
Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?
Read More
Accuray to Participate in the Jefferies Global Healthcare Conference 2025
Published: May 29, 2025 by: PRNewsWire
Sentiment: Neutral
MADISON, Wis. , May 29, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2025.
Read More
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
ARAY continues to witness strength in its flagship, CyberKnife system, along with robust global performance.
Read More
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral
More than 40 Clinical Studies Using Accuray Technology Presented at ESTRO 2025; Company Highlights Innovation and Educational Symposia MADISON, Wis. , May 7, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the benefits of the company's CyberKnife ® System in the treatment of prostate cancer at multiple stages of the cancer journey.
Read More
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Accuray reports solid fiscal third-quarter results, witnessing growth in Product & Services revenues and reduced operating expenses.
Read More
Accuray Incorporated (ARAY) Q3 2025 Earnings Call Transcript
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Neutral
Accuray Incorporated (NASDAQ:ARAY ) Q3 2025 Earnings Call April 30, 2025 4:30 PM ET Company Participants Jesse Chew - Chief Legal Officer Suzanne Winter - President and Chief Executive Officer Ali Pervaiz - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Marie Thibault - BTIG Jason Wittes - ROTH Capital Operator Good day and welcome to the Accuray Third Quarter Fiscal 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Read More
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
Published: March 05, 2025 by: Zacks Investment Research
Sentiment: Positive
ARAY continues to witness strength in its flagship CyberKnife system, along with robust global performance.
Read More
About Accuray Incorporated (ARAY)
- IPO Date 2007-02-08
- Website https://www.accuray.com
- Industry Medical - Specialties
- CEO Suzanne Winter M.B.A.
- Employees 987